Literature DB >> 28552742

Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.

Benjamin K Canales1, Marguerite Hatch2.   

Abstract

BACKGROUND: Hyperoxaluria and oxalate kidney stones frequently develop after Roux-en-Y gastric bypass (RYGB). Oxalobacter formigenes can degrade ingested oxalate.
OBJECTIVES: Examine the effect of O. formigenes wild rat strain (OXWR) colonization on urinary oxalate excretion and intestinal oxalate transport in a hyperoxaluric RYGB model.
SETTING: Basic Science Laboratory, United States.
METHODS: At 21 weeks of age, 28 obese male Sprague-Dawley rats survived Sham (n = 10) or RYGB (n = 18) surgery and were maintained on a 1.5% potassium oxalate, 40% fat diet. At 12 weeks postoperatively, half the animals in each group were gavaged with OXWR. At 16 weeks, percent dietary fat content was lowered to 10%. Urine and stool were collected weekly to determine oxalate and colonization status, respectively. At week 20, [14 C]-oxalate fluxes and electrical parameters were measured in vitro across isolated distal colon and jejunal (Roux limb) tissue mounted in Ussing Chambers.
RESULTS: RYGB animals lost 22% total weight while Shams gained 5%. On a moderate oxalate diet, urinary oxalate excretion was 4-fold higher in RYGB than Sham controls. OXWR colonization, obtained in all gavaged animals, reduced urinary oxalate excretion 74% in RYGB and 39% in Sham and was further augmented by lowering the percentage of dietary fat. Finally, OXWR colonization significantly enhanced basal net colonic oxalate secretion in both groups.
CONCLUSIONS: In our model, OXWR lowered urinary oxalate by luminal oxalate degradation in concert with promotion of enteric oxalate elimination. Trials of O. formigenes colonization and low-fat diet are warranted in calcium oxalate stone formers with gastric bypass and resistant hyperoxaluria.
Copyright © 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric bypass surgery; Hyperoxaluria; Oxalobacter formigenes; Steattorhea

Mesh:

Substances:

Year:  2017        PMID: 28552742      PMCID: PMC5535072          DOI: 10.1016/j.soard.2017.03.014

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  23 in total

1.  Urinary evaluation after RYGBP: a lithogenic profile with early postoperative increase in the incidence of urolithiasis.

Authors:  Antonio Carlos Valezi; Paulo Emilio Fuganti; Jorge Mali Junior; Vinicius Daher Delfino
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

2.  Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion.

Authors:  Juquan Jiang; John Knight; Linda H Easter; Rebecca Neiberg; Ross P Holmes; Dean G Assimos
Journal:  J Urol       Date:  2011-05-14       Impact factor: 7.450

3.  Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.

Authors:  Branden G Duffey; Shaheen Alanee; Renato N Pedro; Bryan Hinck; Carly Kriedberg; Sayeed Ikramuddin; Todd Kellogg; Michelle Stessman; Angela Moeding; Manoj Monga
Journal:  J Am Coll Surg       Date:  2010-07       Impact factor: 6.113

4.  Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.

Authors:  Marguerite Hatch; Altin Gjymishka; Eduardo C Salido; Milton J Allison; Robert W Freel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-16       Impact factor: 4.052

5.  Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.

Authors:  Bernd Hoppe; Jaap W Groothoff; Sally-Anne Hulton; Pierre Cochat; Patrick Niaudet; Markus J Kemper; George Deschênes; Robert Unwin; Dawn Milliner
Journal:  Nephrol Dial Transplant       Date:  2011-04-02       Impact factor: 5.992

6.  Factors related to colonization with Oxalobacter formigenes in U.S. adults.

Authors:  Judith Parsells Kelly; Gary C Curhan; David R Cave; Theresa E Anderson; David W Kaufman
Journal:  J Endourol       Date:  2011-03-07       Impact factor: 2.942

7.  Oxalobacter colonization in the morbidly obese and correlation with urinary stone risk.

Authors:  Branden G Duffey; Ricardo Miyaoka; Ross Holmes; Dean Assimos; Bryan Hinck; Emily Korman; Fred Kieley; Sayeed Ikramuddin; Todd Kellogg; Angela Moeding; Manoj Monga
Journal:  Urology       Date:  2011-05-06       Impact factor: 2.649

8.  Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.

Authors:  Benjamin K Canales; Joseph Ellen; Saeed R Khan; Marguerite Hatch
Journal:  J Urol       Date:  2013-03-14       Impact factor: 7.450

Review 9.  Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies.

Authors:  Benjamin K Canales; Marguerite Hatch
Journal:  Surg Obes Relat Dis       Date:  2014-04-15       Impact factor: 4.734

10.  Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.

Authors:  David W Kaufman; Judith P Kelly; Gary C Curhan; Theresa E Anderson; Stephen P Dretler; Glenn M Preminger; David R Cave
Journal:  J Am Soc Nephrol       Date:  2008-03-05       Impact factor: 10.121

View more
  5 in total

1.  Oxalate secretion is stimulated by a cAMP-dependent pathway in the mouse cecum.

Authors:  Jonathan M Whittamore; Marguerite Hatch
Journal:  Pflugers Arch       Date:  2022-08-31       Impact factor: 4.458

Review 2.  Dietary Recommendations for Bariatric Patients to Prevent Kidney Stone Formation.

Authors:  Milene S Ormanji; Fernanda G Rodrigues; Ita P Heilberg
Journal:  Nutrients       Date:  2020-05-16       Impact factor: 5.717

3.  Distal Gastrectomy with Billroth II Reconstruction is Associated with Oralization of Gut Microbiome and Intestinal Inflammation: A Proof-of-Concept Study.

Authors:  Angela Horvath; Augustinas Bausys; Rasa Sabaliauskaite; Eugenijus Stratilatovas; Sonata Jarmalaite; Burkhard Schuetz; Philipp Stiegler; Rimantas Bausys; Vanessa Stadlbauer; Kestutis Strupas
Journal:  Ann Surg Oncol       Date:  2020-06-05       Impact factor: 5.344

Review 4.  Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?

Authors:  William P Martin; James White; Francisco J López-Hernández; Neil G Docherty; Carel W le Roux
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-17       Impact factor: 5.555

Review 5.  Medical therapy for nephrolithiasis: State of the art.

Authors:  Igor Sorokin; Margaret S Pearle
Journal:  Asian J Urol       Date:  2018-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.